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In vitro bioassays have shown promise as water quality monitoring tools. In this study, four commercially
available in vitro bioassays (GeneBLAzer® androgen receptor (AR), estrogen receptor-alpha (ER), gluco-
corticoid receptor (GR) and progesterone receptor (PR) assays) were adapted to screen for endocrine
active chemicals in samples from two recycled water plants. The standardized protocols were used in an
interlaboratory comparison exercise to evaluate the reproducibility of in vitro bioassay results. Key
performance criteria were successfully achieved, including low background response, standardized
calibration parameters and high intra-laboratory precision. Only two datasets were excluded due to poor
calibration performance. Good interlaboratory reproducibility was observed for GR bioassay, with 16
e26% variability among the laboratories. ER and PR bioactivity was measured near the bioassay limit of
detection and showed more variability (21e54%), although interlaboratory agreement remained com-
parable to that of conventional analytical methods. AR bioassay showed no activity for any of the samples
analyzed. Our results indicate that ER, GR and PR, were capable of screening for different water quality,
i.e., the highest bioactivity was observed in the plant influent, which also contained the highest con-
centrations of endocrine active chemicals measured by LCeMS/MS. After advanced treatment (e.g.,
reverse osmosis), bioactivity and target chemical concentrations were both below limits of detection.
Comparison of bioassay and chemical equivalent concentrations revealed that targeted chemicals
accounted for 5% of bioassay activity, suggesting that detection limits by LCeMS/MS for some chemicals
were insufficient and/or other bioactive compounds were present in these samples. Our study demon-
strated that in vitro bioassays responses were reproducible, and can provide information to complement
conventional analytical methods for a more comprehensive water quality assessment.
© 2015 Elsevier Ltd. All rights reserved.1. Introduction
The scarcity of potable water is a growing issue worldwide,
particularly for urban centers located in arid regions. To fulfill water
supply needs, impacted entities are pursuing policies to increase
the supply and use of recycled water (SWRCB, 2013). Herein weo).define recycled water as highly treated municipal wastewater that
is available for indirect potable reuse (NRMMC, 2009), and ulti-
mately in the future for direct potable reuse (WRRF, 2011). Because
treatedwastewater effluents that serve as source water for recycled
water facilities typically contain chemical residues (Ternes et al.,
2004), purification is needed to attenuate these contaminants.
Prior to widespread public acceptance of potable reuse, recycled
water utilities are faced with the challenge of demonstrating that
chemicals present in product water are not harmful to environ-
mental and human health (WRRF, 2011; SWRCB, 2013).
Table 1
Samples collected from two U.S. water recycling treatment plants. Plant 1 was a fully
operational facility; Plant 2 was operating as a pilot plant at the time of collection.
Sample no. Description
1 Field blank (milli-Q water)
2 Plant 1 e influent (final secondary effluent from WWTP#1)
3 Plant 1 e influent subject to ozonation (Oz)
4 Plant 1 e product water subject to microfiltration (MF)
5 Plant 1 e product water subject to reverse osmosis (RO)
6 Plant 1 e product water subject to ultraviolet (UV)
7 Plant 2 e influent (final secondary effluent from WWTP#2)
8 Plant 2 e influent subject to UV
9 Plant 2 e influent subject to UV/hydrogen peroxide (H2O2)
10 Plant 2 e influent subject to Oz
11 Plant 2 e influent subject to Oz/UV
12 Plant 2 e influent subject to chlorination
WWTP e wastewater treatment plant.
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shown to be a suitable screening alternative for water quality
applications. Many of these assays are used to quantify chemical
bioactivity based on mode of action (MOA), e.g., as part of the
U.S. Environmental Protection Agency (EPA) ToxCast™ and
Endocrine Disruptor Screening Programs (Dix et al., 2007; Reif
et al., 2010). Over the last decade, a number of studies have
applied in vitro bioassays to ascertain the endocrine activity of
surface water and wastewater (van der Linden et al., 2008;
Leusch et al., 2010; Jarosova et al., 2014). Moreover, bioassays
that target molecular initiating events (e.g. gene transactivation)
can be linked to higher order adverse outcomes via toxicity
pathway analyses (Piersma et al., 2013; Sonneveld et al., 2006),
providing additional biological relevance for these tools in the
screening mode. Whereas much of the groundwork has been laid
for endocrine disrupting endpoints, researchers are currently
broadening the scope of bioanalytical tools to include other
relevant MOAs, e.g., genotoxicity, immunotoxicity and oxidative
stress (Escher et al., 2014; Leusch et al., 2014; van der Linden
et al., 2014).
A recent study by Escher et al. (2014) evaluating 103 different
in vitro bioassays to screen for chemicals in wastewater, recycled
water and drinking water, concluded that some of the bioassay
endpoints were capable of discriminating among samples of
different quality. Other studies have reached a similar conclusion,
showing that a few bioassays are capable of relatively good mea-
surement precision (within laboratories) while demonstrating the
ability to differentiate among water qualities (Leusch et al., 2010;
Jarosova et al., 2014). However, these studies have employed bio-
assays that are not widely available, and as a result, lack stan-
dardization across multiple laboratories. To successfully transfer
and implement this technology for water quality monitoring, it is
critical to demonstrate that commercially available bioassays can
be standardized, and that measurements using these standardized
assays agree well across multiple laboratories (Andersen et al.,
1999).
The goals of this study were to 1) develop standardized pro-
tocols using commercially available bioassays for screening water
samples from recycled water treatment process units; 2) evaluate
the reproducibility of the bioassay responses among participating
laboratories; and 3) assess the ability of the bioassays to screen for
water quality by comparing bioassay responses with targeted
chemical occurrence. To accomplish our goals, four “off-the-shelf”
in vitro transactivation bioassays representing different pathways
of the endocrine system were adapted to screen water samples
from two water recycling plants. Replicate aliquots of water ex-
tracts were analyzed by five research laboratories using the stan-
dardized protocols, with bioassay responses translated into
bioanalytical equivalent concentrations and compared with con-
ventional analytical measurements.
2. Materials and methods
2.1. Materials
GeneBLAzer® androgen receptor (AR), estrogen receptor-alpha
(ER), glucocorticoid receptor (GR) and progesterone receptor (PR)
cell assay kits and media components were purchased from Life
Technologies (Carlsbad, CA). Bioassay kits contained division
arrested cells stably transfected with the beta-lactamase reporter
gene, a LiveBLAzer FRET B/G loading kit, and CCF4-AM substrate.
Black wall, clear-bottom 96-well plates were purchased from
Corning (Corning, NY).
Chemicals known or suspected to activate AR (testosterone,
trenbolone), ER (17a-ethinylestradiol, 17a-estradiol, 17b-estradiol,bisphenol A, estriol, estrone), GR (dexamethasone, hydrocortisone,
prednisolone, and triamcinolone), and PR (levonorgestrel, nor-
ethisterone, norgestrel) were purchased at the highest purity
available from SigmaeAldrich (St. Louis, MO). The AR active
chemical methyltrienolone (R1881) was purchased from Per-
kineElmer. Isotopically labeled 17a-ethinylestradiol-13C2, bisphe-
nol A-13C12, estriol-13C3, estrone-13C6 were purchased from
Cambridge Isotope Laboratories (Andover, MA), dexamethasone-d4,
norethindrone-d6 and norgestrel-d6 from C/D/N Isotopes (Pointe-
Claire, Canada), and 17b-estradiol-13C3 and hydrocortisone-d2
from SigmaeAldrich (St. Louis, MO). The purity of all the isotope
standards was 98%.
Molecular grade dimethyl sulfoxide (DMSO, 99.5% purity) was
obtained from SigmaeAldrich (St. Louis, MO). HPLC grade meth-
anol, acetone, acetonitrile, ethyl acetate, hexane and formic acid
were purchased from Fisher Scientific (Pittsburgh, PA).2.2. Sample collection and processing
Grab samples of water (4 L each) were collected in June 2013
from various treatment processes of a fully operational (Plant 1)
and a pilot water recycling plant (Plant 2) located in southwestern
U.S (Table 1). Upon collection, samples containing chlorine were
immediately quenched with sodium thiosulfate (50 mg/L). All
water samples and a field blank sample consisting of milli-Q water
were treated with sodium azide (1 g/L) to inhibit microbial activity
(Vanderford et al., 2011). Samples were stored in methanol-rinsed
amber glass bottles at 4 C and extracted within one week of
collection.
Solid phase extraction (SPE) was performed according to the
methods described by Macova et al. (2011). Briefly, 1 L samples
were filtered and passed through two pre-conditioned cartridges:
a 6 cc Oasis HLB cartridge (Waters, Milford, MA) stacked on top of
a Supelclean coconut charcoal cartridge (Sigma Aldrich). After
rinsing with milli-Q water and vacuum drying for 2 h, the car-
tridges were eluted separately with 10 mL methanol and 10 mL
acetone:hexane (1:1, v/v). For each 4-L water sample, all eluates
were combined and evaporated under a gentle stream of nitro-
gen. Each water extract was then reconstituted in 4 mL methanol
and aliquots of 1.5 mL were stored at 20 C for chemical ana-
lyses. The remaining extract was solvent exchanged to 2.5 mL
DMSO and kept in amber glass vials at 20 C. Aliquot samples of
500 mL were shipped in plastic Eppendorf tubes on ice overnight
to the participating laboratories for blind bioassay analysis,
where they were transferred into amber glass vials and stored
at 20 C.
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To standardize in vitro bioassays protocols to screen water
samples, the following parameters were optimized to: 1) identify
appropriate reference chemicals; 2) determine cell plating density
for a simplified 96-well plate format; and 3) determine suitable
DMSO content per well (see Supplementary Information SI-1).
Optimized bioassay parameters were used to establish standard
operating procedures, including sample dilution protocols and
standardized plate layout that all participating laboratories would
follow.
Standardized bioassay protocols are described in detail in
Supplementary Information SI-1. Briefly, standardized protocols
were developed for a 96-well plate format using GeneBLAzer® AR,
ER, GR and PR division arrested cells. Cell density was set at 40,000
to 50,000 cells per well and solvent vehicle content was set at 0.5%
DMSO per well. For each water extract, four dilutions were pre-
pared in assay-specific media and evaluated for cytotoxic effects
using PrestoBlue (Life Technologies). The diluted water extracts
were then analyzed for AR, ER, GR and PR bioactivity. The REF
(relative enrichment factor), defined as the product of SPE con-
centration factor and bioassay dilution factor, was 5 for the initial
dilution. Raw bioassay fluorescence data, expressed as blue
(460 nm) to green (530 nm) absorbance ratio, were obtained using
a bottom-reading fluorescence plate reader. Bioassay responses
were calibrated using a 9-point assay-specific standard curve, and
the calibrated response was verified on successive plates by
running five concentrations of the reference chemical. Assay media
(cell free), cells and media, and solvent vehicle controls were
analyzed on each plate to correct for bioassay artifacts. All samples
including water extracts, reference chemicals and controls were
run in triplicate. Quality assurance/quality control (QA/QC) criteria
were established to assess the quality of bioassay results obtained
(Tables SI-2 and SI-3).
2.4. Targeted chemical analyses
Sample aliquots preserved for chemical analysis were further
processed to reduce matrix effects using the extraction method of
Chang et al. (2009). Target analytes (Table SI-4) were analyzed
using an Agilent 1290 UHPLC system combined with 6460 triple
quadrupole mass spectrometer (LC-MS/MS) in positive andTable 2
Interlaboratory comparison of calibration performance for GeneBLAzer® estrogen recepto
Results deemed not acceptable were excluded. The calibration performance of the Gene
observed in any of the samples analyzed.
Lab A Lab B
ER (referenced to 17b-estradiol)
Hill slope 1.6 1.6
R2 0.99 0.99
Log EC50 (M) 9.8 9.9
LOD 11 7
Data accepted yes yes
GR (referenced to dexamethasone)
Hill slope 2.3 1.9
R2 0.99 0.99
Log EC50 (M) 8.6 8.5
LOD 5 4
Data accepted yes yes
PR (referenced to levonorgestrel)
Hill slope 2.1 1.8
R2 0.99 1.00
Log EC50 (M) 9.1 9.9
LOD 3 2
Data accepted no yes
LOD e limit of detection, expressed as a percent effect concentration (EC) relative to thenegative electrospray ionization (ESI) mode. ER active chemicals
were analyzed using an Agilent Zorbax Eclipse Plus C8 Rapid Res-
olution HD column (50 mm 2.1 mm,1.8 mm), while AR, GR and PR
active chemicals were analyzed using a C18 Rapid Resolution HD
column (100 mm  2.1 mm, 1.8 mm). Both columns were main-
tained at 30 C at a flow rate of 0.4 mL/min. Gas temperature was
set at 300 C, gas flow was maintained at 11 L/min and the nebu-
lizer was set at 45 psi. An injection volume of 5 mL was used for
analysis of all samples. For ER active chemicals, water (A) and
methanol (B) were used as mobile phases with the following
gradient: 10% B held for 2.5 min, increase to 40% B in 0.5 min, linear
increase to 70% B in 6 min, then to 100% B in 0.1 min and held for
1.0min. For AR, GR and PR active chemicals, 0.1% (v/v) formic acid in
water (A) and acetonitrile (B) were used with the following
gradient: 5% B held for 1.5 min, linear increase to 20% B in 1.5 min,
to 45%B in 1 min, to 65% B in 3 min, up to 100% in 1 min and held at
100% B for 1 min.
Detection parameters used to monitor the thirteen target ana-
lytes are provided in Table SI-4. Instrumental limits of detection
(LODs), method detection limits (MDLs) and sample specific
method reporting limits (MRLs) were determined according to
Anumol and Snyder (2015) (Tables SI-5 and SI-6). For quality con-
trol purposes, at least one laboratory blank and one laboratory
blank sample fortified with the target analytes were analyzed for
every 10 samples.2.5. Data analyses
Raw bioassay fluorescence data were background corrected by
subtracting the average response of the media-only control wells.
Datasets that did not meet the established QA/QC criteria were
excluded from further analyses. The 9-point calibration curve was
used to determine the bioassay specific LOD, calculated as the
minimum calibration response plus two standard deviations of the
mean of that response. Background-corrected fluorescence data
were converted to bioanalytical equivalent concentrations (BEQ,
ng/L) using the equation:
BEQ ¼ EC50 of reference chemical=EC50 of water sample
where EC50 is the 50% effect concentration of the reference chem-
ical or water sample, and EC of water sample is the product ofr-alpha (ER), glucocorticoid receptor (GR) and progesterone receptor (PR) bioassays.
BLAzer® androgen receptor (AR) bioassay was not evaluated as no bioactivity was
Lab C Lab D Lab E
1.4 1.5 1.0
0.99 0.97 0.99
9.6 10.2 9.6
10 4 7
yes no yes
2.5 2.4 2.2
0.99 0.98 1.00
8.4 8.7 8.5
2 9 4
yes yes yes
1.4 1.5 1.3
0.96 0.98 0.99
9.5 9.9 9.5
3 2 8
yes yes yes
referenced chemical.
Fig. 1. Mean bioassay equivalent concentrations (BEQ) for ER (expressed as ng 17b-
estradiol/L ± SD), GR (expressed as ng dexamethasone/L ± SD) and PR (expressed as ng
levonorgestrel/L ± SD) for samples from an operational recycled water facility (Plant 1).
Samples 2, 3, 4 and 5 correspond to Plant 1 influent, OZ e ozonation, MF e micro-
filtration and RO e reverse osmosis, respectively. The median limit of detection (LOD)
was <1.7 ng/L for ER-BEQ, <52 ng/L for GR-BEQ, and <1.4 ng/L for PR-BEQ.
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given samplewas calculated and included for intercomparison if: 1)
extract dilutions exhibited a concentration-dependent response
above the LOD; and 2) the bioassay response fell within the line-
arized portion of the calibration curve (estimated between EC10 and
EC50 of the reference chemical).
3. Results
3.1. Evaluation of individual laboratory performance
All five laboratories successfully employed the standardized
bioassay protocols to conduct a blind analysis of water samples.
Most datasets (12 out of 15) generated for ER, GR and PR bioassays
were deemed satisfactory. The AR assay was not responsive to the
water samples. There was no evidence of cytotoxicity except for
samples 11 and 12 that showed mild cytotoxic effects but at levels
that did not exceed the acceptance threshold (<20% cell mortality,
Table SI-2). All bioassay responses reported for assay media only
and DMSO-exposed cells were in agreement with the QA/QC
criteria shown in Table SI-2. The majority of assay-specific cali-
bration curves also met acceptance thresholds (Table 2). Only two
laboratories, lab A and lab D, reported log EC50 values below the
expected range for PR and ER assays, respectively. These two
datasets were excluded from the calculation of sample BEQs.
Variability in triplicate bioassay responses within a given labora-
tory was sufficiently low (relative standard deviation (RSD) be-
tween 7 and 18%) except for one laboratory that exceeded the 20%
RSD threshold for samples analyzed using the PR bioassay.
3.2. Interlaboratory agreement
Bioactivity was consistently detected in samples 2, 3 and 4 from
Plant 1 (Fig. SI-2). Measured GR-BEQ (expressed as ng dexameth-
asone/L) was highly reproducible, with a coefficient of variation less
than 30% among the five laboratories (Table 3). However the
measured ER bioactivity (expressed as ng 17b-estradiol/L) showed a
higher degree of interlaboratory variation (greater than 30%),
especially for samples 3 and 4 where the measured response was
close to the bioassay LOD (Table 3). Due to unacceptable calibration
performance from one laboratory (Table 2) and poor intra-
laboratory precision from another (above 20% RSD), PR-BEQ
(expressed as ng levonorgestrel/L) was only reported in samples
2 and 3 by three out of the five participating laboratories. The
reproducibility of PR bioassay responses among these laboratories
was intermediate compared to that achieved for GR and ER (21 and
36% RSD, Table 3). Bioassay responses were uniformly belowTable 3
Interlaboratory agreement for analysis of recycled water samples exhibiting activity us
centrations (BEQ, ng/L).
Sample no. ERa GRb
N Mean BEQ % RSD N
2 4 6.5 30 5
3 4 1.5 54 5
4 4 2.6 53 5
5 4 <1.7 N/A 5
6 4 <1.7 N/A 5
N e number of laboratories meeting QA/QC criteria.
RSD e relative standard deviation.
N/A e not applicable.
Below detection is represented by “<median limit of detection” (e.g. “<1.7”).
a ER-BEQ expressed as ng 17b-estradiol/L.
b GR-BEQ expressed as ng dexamethasone/L.
c PR-BEQ expressed as ng levonorgestrel/L.detection levels for all samples collected from Plant 2 (samples
7e12). None of the participating laboratories detected AR activity
above LOD in the water samples. Thus, AR bioassay results were not
used for this interlaboratory comparison exercise.3.3. Bioscreening of water quality
Patterns of bioassay responses were in agreement with the
quality of the water samples assessed by LC-MS/MS. The highest
level of ER, GR and PR bioactivity was detected in the Plant 1
influent extract (sample 2), which contained the highest concen-
trations of target analytes and was thus considered to have the
lowest water quality (Fig. 1, Table SI-6). The mean GR-, ER- and PR-
BEQ for sample 2 were estimated at 90 ng dexamethasone/L, 6.5 ng
17b-estradiol/L and 5.7 ng levonorgestrel/L, respectively. Ozonation
(sample 3) led to a reduction of ER, GR and PR bioactivity. Following
microfiltration (sample 4), the mean PR-BEQ was below detection
limits. However, ER and GR bioactivities were detected in this
sample at concentrations equivalent to 2.6 ng 17b-estradiol/L and
65 ng dexamethasone/L, respectively. At the highest level of
treatment (samples 5 and 6), bioassay responses were no longer
detected. None of the laboratories detected a bioassay response in
the field blank (sample 1).ing GeneBLAzer® bioassays. Results are expressed as bioanalytical equivalent con-
PRc
Mean BEQ % RSD N Mean BEQ % RSD
90 26 3 5.7 36
61 16 3 2.2 21
65 23 3 <1.4 N/A
<52 N/A 3 <1.4 N/A
<52 N/A 3 <1.4 N/A
Table 4
Comparison of bioanalytical and chemical equivalent concentrations (BEQs and CEQs, respectively), both expressed in ng/L.
Sample no. CEQs for estrogensa Sum CEQ Percent BEQ explainedc CEQs for glucocorticoidsb Sum CEQ Percent BEQ explainedc
aE2 bE2 E1 EE2 E3 BPA DEX HYD PRED TRIM
2 <0.51 <1.3 0.13 <12.9 <0.058 0.00046 0.13 2 <0.18 0.24 0.09 <0.04 0.52 0.4
3 <0.47 <1.2 0.05 <7.0 <0.073 0.00003 0.05 4 <0.17 0.22 0.07 <0.04 0.49 0.5
4 <0.49 <1.2 0.13 <8.6 <0.08 0.00006 0.13 5 <0.16 0.2 0.06 <0.04 0.46 0.4
REPd 0.011 1 0.027 5.03 0.017 0.000016 1.00 0.26 0.21 0.15
a aE2 ¼ 17a-estradiol, bE2 ¼ 17b-estradiol, E1 ¼ estrone; EE2 ¼ 17a-ethinylestradiol, E3 ¼ estriol, BPA ¼ bisphenol A.
b DEX ¼ dexamethasone; HYD ¼ hydrocortisone, PRED ¼ prednisolone, TRI ¼ triamcinolone.
c (sum CEQ/mean BEQ)* 100; mean BEQs are from Table 3.
d REP (unpublished data) e relative effect potency factor, calculated as EC50 of the reference compound/EC50 of the test compound.
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Concentrations of ER and GR active chemicals frequently
detected in wastewater as determined by LCeMS/MS are shown in
Table SI-6. Many of the chemicals detected had low relative effect
potency (REP, Table 4). Chemical equivalent concentrations (CEQs),
defined as the sum of the product of agonist concentrations
determined by LC-MS/MS and their REP, were calculated for each
water sample. Targeted chemistry data explained less than 10% of
the ER bioassay responses and less than 1% of the GR bioassay re-
sponses (Table 4). PR bioassay responses could not be explained, as
the two known PR active chemicals analyzed in this study were
below analytical detection limits.4. Discussion
Standardization is a critical step in establishing robust meth-
odologies that allow multiple entities to produce comparable re-
sults. In the present study, performance-based QA/QC criteria
(Table SI-2) were established to control for poor method perfor-
mance due to (1) cytotoxicity; (2) interferences from media and
solvents (“background response”); and (3) variability in calibration
response. All participating laboratories achieved results within the
acceptance thresholds for cytotoxicity and background response,
indicating that the likelihood of matrix interference was small.
During optimization of our protocols, we observed first-hand the
negative impact that both parameters can exert on the bioassay
response if not properly controlled. Cytotoxicity is particularly
important to implement for cell bioassays to confirm that non-
responses are an accurate representation of non-bioactivity, and
are not caused by sample exposure issues with cell viability.
Our standardized protocols and QA/QC criteria are consistent
with those established for ER transactivation bioassays employed in
the Endocrine Disruptor Screening Program (EDSP) (USEPA, 2012).
For example, the 9-point calibration curve over four logs of con-
centration of reference chemical in our protocols compares favor-
ably to those employed in the EDSP, which vary between single
point (i.e., one concentration) to 16-point calibration curves
stretching over 10 orders of magnitude. In the present study, the
laboratories were able to routinely operate within the established
QA/QC criteria for calibration. Verification of calibration response
performed to assess plate-to-plate and day-to-day variation
revealed that calibration was adequately stable. There were only 2
out of 15 incidences where a laboratory failed to meet the QA/QC
criteria for the calibration curve (Table 2), confirming that bioassay
methodologies have matured in reliability and emphasizing the
importance of routinely monitoring QA/QC parameters to ensure
reliable bioassay results (Leusch et al., 2010; Macova et al., 2011). In
both cases, the estimated EC50 for the reference chemical and/or
the Hill slope fell outside of the acceptance range by a slightmargin.
Further refinement of the protocols to confirm accurate preparationof reference chemical stock solutions and dilutions could improve
calibration performance.
Bioassay response patterns for ER and GR were similar across
laboratories, with samples 2e4 showing clear bioactivity and the
remaining samples showing little evidence of activity above LODs
(Fig. SI-2). The response patterns for AR and PR were more variable
as bioassay responses were often close to or below the LOD
(Table 3). Interlaboratory agreement was highest in estimating
mean GR-BEQs (16e26% RSD; Table 3). This is to be expected since
the GR responses for samples 2e4 were the highest measured.
Mean ER-BEQs for four laboratories (data from the fifth laboratory
did not meet QA/QC criteria) agreed to within a factor of 2 (54%
RSD), and mean PR-BEQs estimated for three laboratories agreed to
within 36%. The level of interlaboratory agreement achieved was
similar in both magnitude and range (10%e~50%) to the variability
noted in previous studies. van der Linden et al. (2008) reported an
intra-laboratory variability for triplicate analysis of WWTP effluent
samples ranging from 10% for ER to 35% RSD for GR and PR assays.
In the same study, samples' variability increased to approximately
40% for surface and drinking water samples, which is lower but
consistent with our results for highly treated samples. In another
study that measured estrogenicity of single chemicals in human
breast cancer (MCF-7) cells, the interlaboratory agreement ranged
from 10 to 50% (Andersen et al., 1999).
Our results also indicate that the level of interlaboratory
reproducibility attained using the standardized bioassays is
approaching that achievable using conventional analytical chem-
istry. Interlaboratory agreement for targeted chemical analyses
using environmental samples can range from single digit to more
than 50% RSD, depending on the analyte, matrix and measured
concentration (Vanderford et al., 2014). It should be noted that the
present study addresses only the reproducibility of bioassay re-
sponses since a single laboratory collected and processed all the
samples. Other factors including extraction method, collection,
handling and preservation can have a significant impact on repro-
ducibility especially when dealing with exceedingly low concen-
trations of chemicals. In our study, aliquots of sample extracts in
DMSO were shipped in plastic Eppendorf tubes. The timing of
subsequent transfer into glass vials varied among laboratories. This
may have resulted in a variable loss of extractable residues, thus
affecting the interlaboratory agreement in bioactivity
measurements.
The in vitro bioassays evaluated were capable of qualitatively
ranking samples from Plant 1 by water quality (Fig. 1). For example,
the reduction in mean bioactivity measured for Plant 1 influent
after microfiltration (sample 4) is in agreement with the reduction
in bioassay response observed by Escher et al. (2014) for recycled
water subjected to ultrafiltration. Bioactivity of all three endpoints
was below LODs inwater subjected to RO and UV (samples 5 and 6),
consistent with bioassay screening results published earlier (Escher
et al., 2014; Leusch et al., 2014). In contrast, AR revealed no pattern
A.C. Mehinto et al. / Water Research 83 (2015) 303e309308among the 12 samples analyzed. It should be noted that anti-AR
activity has often been observed in the environment and this
endpoint may be a more relevant MOA for bioscreening of chem-
icals (Escher et al., 2014; USEPA, 2014).
The contribution of two known ER agonists detected by LCeMS/
MS e estrone and bisphenol A e accounted for up to 5% of the
measured BEQs (Table 4). The discrepancy between GR-BEQ and
CEQ estimated for hydrocortisone and prednisolone was even
greater, accounting for less than 1% of measured GR-BEQs (Table 4).
Previous studies have shown good agreement between bio-
analytical equivalent concentrations and the levels of natural and
synthetic hormones present in water samples (Leusch et al., 2010;
Tang et al., 2014). In the present study, relating the measured bio-
logical activity to individual chemicals was made difficult for two
reasons: few chemicals were monitored by targeted chemical an-
alyses (four GR agonists and two PR agonists, Table SI-4), and there
were relatively high analytical method reporting limits (MRLs) for
some of the potent estrogens. Previous studies have shown that a
variety of synthetic glucocorticoids, including but not limited to
those selected here, can contribute to overall GR activity in water
samples (Schriks et al., 2010; Suzuki et al., 2014), and the same is
likely to hold true for progestins and PR activity. For ER activity, the
relatively high MRLs for 17b-estradiol and 17a-ethinylestradiol
(0.4e1.3 and 0.5e2.4 ng/L, respectively) may have impacted the
CEQ to BEQ comparison, as either of these compounds present just
below their respective MRLs could account for the majority of the
biological activity detected in vitro. Furthermore, assessing the
mass balance between BEQ and CEQ relies on the accurate esti-
mation of REPs of known agonists. Although the REP utilized in our
study were within the same order of magnitude as those published
previously (Leusch et al., 2014; Schriks et al., 2010), additional
standardization of REP values is needed to establish consensus
across cell lines for the same endpoint.
5. Conclusions
Standardization of bioassay protocols and QA/QC guidelines
resulted in good interlaboratory agreement when applying
commercially available in vitro transactivation bioassays for
screening of recycled water samples. Bioassays that showed
reproducible responses among the participating laboratories, and
thus potential to assess water quality include ER, GR and PR in
agonist mode. Androgenic activity was not observed; however,
antagonist mode AR would represent an additional reasonable
endpoint for screening of endocrine active chemicals in
wastewater-derived sources.
The suite of estrogenic hormones and pervasive synthetic
chemicals typically targeted in current monitoring efforts could not
be quantitatively related to the bioactivity observed in this study. It
is likely that inclusion of additional compounds and improvements
in the detection of trace chemicals by targeted chemistry methods
would improve the correlation between CEQ and BEQ. However,
questions remain as to the identity of other bioactive substances in
these samples. A strategy that incorporates bioanalytical, targeted
and non-targeted chemical screening would constitute a more
comprehensive and effects-directed monitoring effort (Snyder,
2014). Should screening using in vitro bioassays and targeted
chemical analysis warrant further investigation, non-targeted
chemical analysis could be implemented to identify the other
chemicals contributing to the bioactivity.
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